{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:42:54Z","timestamp":1792687374758,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.reprotox.2026.109387","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:12:47Z","timestamp":1792451567000},"page":"109387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\"Mirabegron as a protective agent in testosterone-induced prostate and seminal vesicle toxicity: Insights into PCNA and TLR-4 pathways\""],"prefix":"10.1016","volume":"146","author":[{"given":"Sarah Sameh","family":"Abdel-Hameed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5971-1104","authenticated-orcid":false,"given":"Mahmoud","family":"El-Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa I.","family":"Matouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2026.109387_bib1","first-page":"123","article-title":"Testosterone, bone and osteoporosis","volume":"37","author":"Francis","year":"2009","journal-title":"Front. Horm. Res."},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/acel.12052","article-title":"Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells","volume":"12","author":"Guo","year":"2013","journal-title":"Aging Cell."},{"issue":"3","key":"10.1016\/j.reprotox.2026.109387_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.4158\/PS-2019-0540","article-title":"Off-label use and misuse of testosterone, growth hormone, thyroid hormone, and adrenal supplements: risks and costs of a growing problem","volume":"26","author":"Irwig","year":"2020","journal-title":"Endocr. Pract."},{"issue":"6","key":"10.1016\/j.reprotox.2026.109387_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s12098-023-04577-x","article-title":"Delayed puberty","volume":"90","author":"Mohanraj","year":"2023","journal-title":"Indian. J. Pediatr."},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cen.14633","article-title":"Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism","volume":"96","author":"Jayasena","year":"2022","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.reprotox.2026.109387_bib6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/jcm8030410","article-title":"Evolution of guidelines for testosterone replacement therapy","volume":"8","author":"Park","year":"2019","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.reprotox.2026.109387_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.21037\/tau.2016.08.15","article-title":"Off label therapies for testosterone replacement.","volume":"5","author":"DiGiorgio","year":"2016","journal-title":"Transl. Androl. Urol."},{"issue":"3","key":"10.1016\/j.reprotox.2026.109387_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ando.2023.03.025","article-title":"Doping with testosterone and androgenic\/anabolic steroids: Impact on health, screening tools and medical care","volume":"84","author":"Young","year":"2023","journal-title":"Ann. D. 'Endocrinol."},{"issue":"8","key":"10.1016\/j.reprotox.2026.109387_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0309160","article-title":"Cross-sectional analysis of national testosterone prescribing through prescription drug monitoring programs, 2018\u20132022","volume":"19","author":"Selinger","year":"2024","journal-title":"PLoS. One"},{"issue":"17","key":"10.1016\/j.reprotox.2026.109387_bib10","first-page":"1478","article-title":"FDA updates testosterone labeling for blood pressure and cardiovascular risks","volume":"333","author":"Anderer","year":"2025","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.reprotox.2026.109387_bib11","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.reprotox.2026.109387_bib12","article-title":"Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review.\" Medical Science","volume":"29","author":"Kwiatka","year":"2025"},{"key":"10.1016\/j.reprotox.2026.109387_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-019-1384-0","article-title":"The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review.","volume":"20","author":"Davani-Davari","year":"2019","journal-title":"BMC Nephrol."},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib14","first-page":"106","article-title":"Exogenous testosterone: a preventable cause of male infertility","volume":"2","author":"Crosnoe","year":"2013","journal-title":"Transl. Androl. Urol."},{"issue":"8","key":"10.1016\/j.reprotox.2026.109387_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/medicines11080020","article-title":"Safety implications of off-label medication use in athletes: a narrative review","volume":"11","author":"Silva","year":"2024","journal-title":"Medicines"},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4103\/1008-682X.140966","article-title":"Testosterone and benign prostatic hyperplasia","volume":"17","author":"Jarvis","year":"2015","journal-title":"Asian J. Androl."},{"issue":"9","key":"10.1016\/j.reprotox.2026.109387_bib17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1464-410X.2008.08240.x","article-title":"Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy","volume":"103","author":"Coward","year":"2009","journal-title":"BJU Int."},{"issue":"13","key":"10.1016\/j.reprotox.2026.109387_bib18","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1200\/JCO.2016.69.5304","article-title":"Testosterone replacement therapy and risk of favorable and aggressive prostate cancer","volume":"35","author":"Loeb","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.reprotox.2026.109387_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/pros.23365","article-title":"Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume","volume":"77","author":"Pej\u010di\u0107","year":"2017","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.reprotox.2026.109387_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.urology.2007.05.025","article-title":"Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men","volume":"70","author":"Liu","year":"2007","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.reprotox.2026.109387_bib21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000366210","article-title":"Oxidative stress in benign prostatic hyperplasia: a systematic review","volume":"94","author":"Minciullo","year":"2015","journal-title":"Urol. Int."},{"issue":"5","key":"10.1016\/j.reprotox.2026.109387_bib22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/14796694.4.5.637","article-title":"Inflammation and prostate cancer","volume":"4","author":"Vasto","year":"2008","journal-title":"Future Oncol."},{"issue":"5","key":"10.1016\/j.reprotox.2026.109387_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1517\/17425255.2013.786700","article-title":"The pharmacokinetic evaluation of mirabegron as an overactive bladder therapy option","volume":"9","author":"Kashyap","year":"2013","journal-title":"Expert. Opin. Drug. Metab. & Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2026.109387_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018802","article-title":"The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: a systematic review and meta-analysis","volume":"99","author":"Su","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.reprotox.2026.109387_bib25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11934-013-0363-4","article-title":"Mirabegron for male lower urinary tract symptoms","volume":"14","author":"Suarez","year":"2013","journal-title":"Curr. Urol. Rep."},{"issue":"4","key":"10.1016\/j.reprotox.2026.109387_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/pros.22930","article-title":"The beta-3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: new therapeutic indication?\"","volume":"75","author":"Calmasini","year":"2015","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.reprotox.2026.109387_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/JCMRP.JCMRP_40_19","article-title":"Hepatoprotective and antiobesity effects of mirabegron, a novel \u03b23-adrenoceptor agonist, on carbon tetrachloride-induced hepatotoxicity in obese rats","volume":"5","author":"Elbadr","year":"2020","journal-title":"J. Curr. Med. Res. Pract."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib28","doi-asserted-by":"crossref","first-page":"17495","DOI":"10.1038\/s41598-021-96815-5","article-title":"Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.","volume":"11","author":"Kov\u00e1cs","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.reprotox.2026.109387_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153586","article-title":"Mirabegron alleviates acetic acid-induced colitis in rats: role of adiponectin and GSTM1\/GSH detoxification pathway","volume":"494","author":"Mohamed","year":"2023","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib30","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1038\/s41467-023-43350-8","article-title":"Mirabegron displays anticancer effects by globally browning adipose tissues","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.reprotox.2026.109387_bib31","first-page":"1097","article-title":"Mirabegron for Cardiac Disease: A New Therapeutic Frontier.","volume":"10","author":"Tran","year":"2025","journal-title":"Cardiol. Rev."},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/ph15020130","article-title":"Aescin protects against experimental benign prostatic hyperplasia and preserves prostate histomorphology in rats via suppression of inflammatory cytokines and cox-2.","volume":"15","author":"Raafat","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.reprotox.2026.109387_bib33","series-title":"Theory and practice of histological techniques","author":"Bancroft","year":"2008"},{"issue":"5","key":"10.1016\/j.reprotox.2026.109387_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0093-691X(99)00038-2","article-title":"Development and application of competitive ELISA assays for rat LH and FSH","volume":"51","author":"Pappa","year":"1999","journal-title":"Theriogenology"},{"key":"10.1016\/j.reprotox.2026.109387_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112199","article-title":"Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.","volume":"143","author":"Almukadi","year":"2021","journal-title":"Biomed. & Pharmacother."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib36","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12906-021-03472-2","article-title":"Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats","volume":"21","author":"Shabani","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cber.187901201117","article-title":"Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt \u201eUeber einige Azoverbindungen","volume":"12","author":"Griess","year":"1879","journal-title":"Ber. der Dtsch. Chem. Ges."},{"key":"10.1016\/j.reprotox.2026.109387_bib38","first-page":"148","article-title":"Current protocol for light microscopy immunocytochemistry","volume":"II","author":"C\u00f4t\u00e9","year":"1993","journal-title":"Immunohistochemistry"},{"issue":"10","key":"10.1016\/j.reprotox.2026.109387_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109219","article-title":"The impact of exogenic testosterone and nortestosterone-decanoate toxicological evaluation using a rat model","volume":"9","author":"Cristina","year":"2014","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.reprotox.2026.109387_bib40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.cellbi.2006.01.002","article-title":"Differential proliferative response of the ventral prostate and seminal vesicle to testosterone replacement","volume":"30","author":"Justulin","year":"2006","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.reprotox.2026.109387_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cont.2024.101711","article-title":"Testosterone and 5 alpha reductase inhibitor (5ARI) in benign prostatic hyperplasia (BPH): a historical perspective","volume":"12","author":"Diokno","year":"2024","journal-title":"Continence"},{"key":"10.1016\/j.reprotox.2026.109387_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1677\/ERC-08-0084","article-title":"Androgen receptor and growth factor signaling cross-talk in prostate cancer cells","volume":"15","author":"ML","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"2-3","key":"10.1016\/j.reprotox.2026.109387_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/09687688.2014.894211","article-title":"Evidence of TGF-\u03b2 1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells","volume":"31","author":"Hu","year":"2014","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.reprotox.2026.109387_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114389","article-title":"Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-\u03b21\/Smad signaling pathway.","volume":"160","author":"Kim","year":"2023","journal-title":"Biomed. & Pharmacother."},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib45","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2004.04.028","article-title":"Transforming growth factor \u03b21 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species","volume":"37","author":"Li","year":"2004","journal-title":"Free. Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.reprotox.2026.109387_bib46","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/sj.onc.1208262","article-title":"TGF \u03b21 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells","volume":"24","author":"Yoon","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/mend-4-2-349","article-title":"Follicle-stimulating hormone regulation of androgen-binding protein messenger RNA in Sertoli cell cultures","volume":"4","author":"Hall","year":"1990","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.reprotox.2026.109387_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2024.1379272","article-title":"Abusive use of anabolic androgenic steroids, male sexual dysfunction and infertility: an updated review","volume":"6","author":"Azevedo","year":"2024","journal-title":"Front. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2026.109387_bib49","first-page":"1981","article-title":"EFFICACY OF MIRABEGRON ADD-ON THERAPY TO SILODOSIN FOR THE TREATMENT OF PERSISTENT STORAGE SYMPTOMS IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA","volume":"31","author":"Khumukcham","year":"2024","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.reprotox.2026.109387_bib50","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/pros.23195","article-title":"NF-\u03baB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance","volume":"76","author":"Austin","year":"2016","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.reprotox.2026.109387_bib51","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.3390\/ijms23042201","article-title":"Investigation of the antiremodeling effects of losartan, mirabegron and their combination on the development of doxorubicin-induced chronic cardiotoxicity in a rat model.","volume":"23","author":"Freiwan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.reprotox.2026.109387_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12012-011-9105-3","article-title":"High-dose testosterone propionate treatment reverses the effects of endurance training on myocardial antioxidant defenses in adolescent male rats.","volume":"11","author":"Sadowska-Kr\u0119pa","year":"2011","journal-title":"Cardiovasc. Toxicol."},{"issue":"6","key":"10.1016\/j.reprotox.2026.109387_bib53","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/and.12032","article-title":"Effect of exogenous testosterone on oxidative status of the testes in adult male rats","volume":"45","author":"Tothova","year":"2013","journal-title":"Andrologia"},{"issue":"4","key":"10.1016\/j.reprotox.2026.109387_bib54","first-page":"11593","article-title":"Effects of testosterone replacement on lipid profile, hepatotoxicity, oxidative stress, and cognitive performance in castrated wistar rats","volume":"95","author":"Boukari","year":"2023","journal-title":"Arch. Ital. Urol. Androl."},{"issue":"35","key":"10.1016\/j.reprotox.2026.109387_bib55","doi-asserted-by":"crossref","first-page":"27986","DOI":"10.1039\/C4RA13315C","article-title":"Free radicals, natural antioxidants, and their reaction mechanisms","volume":"5","author":"Nimse","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.reprotox.2026.109387_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108082","article-title":"Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis","volume":"100","author":"El-Sherbiny","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.reprotox.2026.109387_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.taap.2016.09.024","article-title":"Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.","volume":"311","author":"Sayed","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: Regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"49","key":"10.1016\/j.reprotox.2026.109387_bib59","doi-asserted-by":"crossref","first-page":"31138","DOI":"10.1074\/jbc.272.49.31138","article-title":"Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms","volume":"272","author":"Kim","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.reprotox.2026.109387_bib60","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.reprotox.2026.109387_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0418-8","article-title":"Oxidative stress in prostate hyperplasia and carcinogenesis","volume":"35","author":"Udensi","year":"2016","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MOU.0b013e32835abd4a","article-title":"Correlation between benign prostatic hyperplasia and inflammation","volume":"23","author":"Bostanci","year":"2013","journal-title":"Curr. Opin. Urol."},{"issue":"10","key":"10.1016\/j.reprotox.2026.109387_bib63","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.bbamcr.2017.07.003","article-title":"Beta3 adrenergic receptor stimulation in human macrophages inhibits NADPHoxidase activity and induces catalase expression via PPAR\u03b3 activation","volume":"1864","author":"Hadi","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"10.1016\/j.reprotox.2026.109387_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.117816","article-title":"\"Neuroprotective role of mirabegron: Targeting beta-3 adrenergic receptors to alleviate ulcerative colitis-associated cognitive impairment.","volume":"183","author":"Nasser","year":"2025","journal-title":"Biomed. & Pharmacother."},{"key":"10.1016\/j.reprotox.2026.109387_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111289","article-title":"Mirabegron, dependent on \u03b23-adrenergic receptor, alleviates mercuric chloride-induced kidney injury by reversing the impact on the inflammatory network, M1\/M2 macrophages, and claudin-2.","volume":"126","author":"Kamal","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib66","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/13880209.2021.1953539","article-title":"Curcumin attenuates prostatic hyperplasia caused by inflammation via up-regulation of bone morphogenetic protein and activin membrane-bound inhibitor","volume":"59","author":"Liu","year":"2021","journal-title":"Pharm. Biol."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib67","doi-asserted-by":"crossref","first-page":"27051","DOI":"10.1038\/srep27051","article-title":"LPS\/TLR4 signaling enhances TGF-\u03b2 response through downregulating BAMBI during prostatic hyperplasia","volume":"6","author":"He","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.reprotox.2026.109387_bib68","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.freeradbiomed.2010.01.006","article-title":"Linking oxidative stress to inflammation: Toll-like receptors","volume":"48","author":"Gill","year":"2010","journal-title":"Free. Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.reprotox.2026.109387_bib69","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1007\/s00210-025-04874-6","article-title":"Protective role of agomelatine via modulation of TLR4\/NF-\u03baB: NLRP3\/IL-1\u03b2 signaling pathways in testosterone-induced benign prostatic hyperplasia in rats","volume":"399","author":"Abdel-Aziz","year":"2026","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"key":"10.1016\/j.reprotox.2026.109387_bib70","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.08.026","article-title":"Potential therapeutic targets for inflammation in toll-like receptor 4 (TLR4)-mediated signaling pathways","volume":"40","author":"Roy","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"3-4","key":"10.1016\/j.reprotox.2026.109387_bib71","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vetimm.2015.10.003","article-title":"Activation of MEK\/ERK pathways through NF-\u03baB activation is involved in interleukin-1\u03b2-induced cyclooxygenease-2 expression in canine dermal fibroblasts","volume":"168","author":"Tsuchiya","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"10","key":"10.1016\/j.reprotox.2026.109387_bib72","doi-asserted-by":"crossref","first-page":"14425","DOI":"10.1007\/s00210-025-04215-7","article-title":"Ripasudil, a Rho kinase inhibitor, attenuates testosterone-induced benign prostatic hyperplasia in rats: targeting inflammation, oxidative stress, and Rho kinase pathways","volume":"398","author":"Aljorani","year":"2025","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.reprotox.2026.109387_bib73","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.114.218693","article-title":"Interleukin-driven insulin-like growth factor promotes prostatic inflammatory hyperplasia","volume":"351","author":"Hahn","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.reprotox.2026.109387_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176617","article-title":"Role of cAMP\/pCREB and GSK-3\u03b2\/NF-\u03baB p65 signaling pathways in the renoprotective effect of mirabegron against renal ischemia-reperfusion injury in rats.","volume":"974","author":"Ahmed","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.reprotox.2026.109387_bib75","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/ph17111516","article-title":"Prunella vulgaris extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating androgen levels, cell proliferation, and apoptosis","volume":"17","author":"Kumbukgahadeniya","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.reprotox.2026.109387_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293682","article-title":"Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-\u03b1 in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach","volume":"18","author":"Rasheed","year":"2023","journal-title":"PLoS. One"},{"issue":"15","key":"10.1016\/j.reprotox.2026.109387_bib77","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners","volume":"116","author":"Maga","year":"2003","journal-title":"J. Cell. Sci."},{"issue":"1","key":"10.1016\/j.reprotox.2026.109387_bib78","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.25011\/cim.v31i1.3136","article-title":"Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia","volume":"31","author":"Zhong","year":"2008","journal-title":"Clin. Invest. Med."},{"issue":"11","key":"10.1016\/j.reprotox.2026.109387_bib79","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1021\/acschembio.9b00338","article-title":"Procaspase-3 overexpression in cancer: a paradoxical observation with therapeutic potential","volume":"14","author":"Boudreau","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.reprotox.2026.109387_bib80","first-page":"201","volume":"115","author":"Allen","year":"2024"},{"key":"10.1016\/j.reprotox.2026.109387_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1008085","article-title":"The novel anti-colitic effect of \u03b2-adrenergic receptors via modulation of PS1\/BACE-1\/A\u03b2 axis and NOTCH signaling in an ulcerative colitis model.","volume":"13","author":"Nasser","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.reprotox.2026.109387_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-016-0567-0","article-title":"Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension.","volume":"111","author":"Garc\u00eda-\u00c1lvarez","year":"2016","journal-title":"Basic. Res. Cardiol."},{"issue":"12","key":"10.1016\/j.reprotox.2026.109387_bib83","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/cells9122584","article-title":"The beta3 adrenergic receptor in healthy and pathological cardiovascular tissues","volume":"9","author":"Michel","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.reprotox.2026.109387_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11596-016-1533-7","article-title":"\u03b23-adrenoceptor impacts apoptosis in cultured cardiomyocytes via activation of PI3K\/Akt and p38MAPK.","volume":"36","author":"Ma","year":"2016","journal-title":"J. Huazhong Univ. Sci. Technol. [Med. Sci. ]"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623826002303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623826002303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:34:01Z","timestamp":1792686841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623826002303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":84,"alternative-id":["S0890623826002303"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2026.109387","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\"Mirabegron as a protective agent in testosterone-induced prostate and seminal vesicle toxicity: Insights into PCNA and TLR-4 pathways\"","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2026.109387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109387"}}